D.E. Shaw & Co’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Sell |
10,586
-46,518
| -81% | -$522K | ﹤0.01% | 2881 |
|
|
2025
Q1 | $261K | Buy |
57,104
+19,120
| +50% | +$87.4K | ﹤0.01% | 2697 |
|
|
2024
Q4 | $214K | Buy |
+37,984
| New | +$214K | ﹤0.01% | 2716 |
|
|
2024
Q2 | – | Sell |
-310,205
| Closed | -$4.12M | – | 3488 |
|
|
2024
Q1 | $4.12M | Buy |
310,205
+88,158
| +40% | +$1.17M | ﹤0.01% | 1372 |
|
|
2023
Q4 | $3.1M | Buy |
+222,047
| New | +$3.1M | ﹤0.01% | 1500 |
|
|
2022
Q4 | – | Sell |
-7,062
| Closed | -$243K | – | 3813 |
|
|
2022
Q3 | $243K | Sell |
7,062
-87,063
| -92% | -$3M | ﹤0.01% | 3150 |
|
|
2022
Q2 | $1.44M | Buy |
94,125
+3,119
| +3% | +$47.7K | ﹤0.01% | 2482 |
|
|
2022
Q1 | $2.08M | Buy |
91,006
+78,380
| +621% | +$1.79M | ﹤0.01% | 2400 |
|
|
2021
Q4 | $466K | Sell |
12,626
-88,840
| -88% | -$3.28M | ﹤0.01% | 3121 |
|
|
2021
Q3 | $4.77M | Buy |
101,466
+43,647
| +75% | +$2.05M | ﹤0.01% | 1488 |
|
|
2021
Q2 | $3.48M | Buy |
+57,819
| New | +$3.48M | ﹤0.01% | 1659 |
|